Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzo Biochem Inc (NYSE:ENZ)

6.54
Delayed Data
As of Jul 22
 +0.04 / +0.62%
Today’s Change
2.57
Today|||52-Week Range
6.85
+45.33%
Year-to-Date
Why Juno Therapeutics (JUNO) Could Be Positioned for a Slump
Jul 15 / Zacks.com - Paid Partner Content
TrovaGene Inks Partnership with USC Norris Cancer Center
Jul 13 / Zacks.com - Paid Partner Content
Should You Get Rid of Emergent BioSolutions (EBS) Now?
Jul 15 / Zacks.com - Paid Partner Content
Strength Seen in Heska (HSKA): Stock Jumps 5.7% in Session
Jul 11 / Zacks.com - Paid Partner Content
5 Low Priced Breakout Stocks with Superlative Returns
Jul 14 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for July 11th
Jul 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close6.50
Today’s open6.50
Day’s range6.46 - 6.60
Volume176,656
Average volume (3 months)263,729
Market cap$302.6M
Dividend yield--
Data as of 4:02pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+78.26%
Earnings growth (this year)+23.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+1.72%
P/E ratio17.2
Price/Sales1.39
Price/Book7.07

Competitors

 Today’s
change
Today’s
% change
BSTCBiospecifics Technol...-0.36-0.87%
ARWRArrowhead Pharmaceut...+0.07+1.25%
AVXLAnavex Life Sciences...-0.25-3.52%
NVIVInVivo Therapeutics ...+0.04+0.61%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateOctober 11, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$97.6M
Annual profit (last year)-$2.3M
Net profit margin-2.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer, Director &
CAO
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs